Drawing for VIRAMEDX

USPTO serial 78290939

VIRAMEDX

Reviewed by CopyMark Law Group

Reg. 2946761Status 710
Filing date
Status date
Registration date
May 3, 2005
Examiner
SPRUILL, DARRYL M
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with VIRAMEDX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Thomas W. Tolpin

THOMAS W TOLPIN Tolpin & Partners, PC11 S. LaSalle StreetSuite 2900Chicago, IL 60603

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparation with antiviral and/or antimicrobial properties for herpes related microbial infections, namely, herpes simplex virus, varicella zoster virus "herpes zoster" "shingles", cytomegalovirus, and cold sores and for use in the treatment of herpetic keratitis, conjunctivitis, HIV retinopathy, viral influenza "flu", herpes simplex virus 1, herpes simplex virus 2, esptein barr, papilloma virus, viral parainfluenza, adenovirus, viral encephalits, viral menigitus, arbovirus, arenavirus, picornavirus, coronavirus, syntialvirus, viral infections, common colds caused by viruses, human immunedeficiency virus "HIV", geniculate zoster, chicken pox, roseola infantum, organ transplant rejection, pneumonia, infectious mononucleosis, uveitis, retinitis, human cervical carcinoma, vaginal carcinoma, vulvovaginitis, human herpes IV, and Kaposi's sarcomaSECTION 8 - CANCELLEDJan 31, 1997

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 2, 2020ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Jul 22, 2015ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Dec 9, 2011C8..CANCELLED SEC. 8 (6-YR)—
May 20, 2008TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 3, 2005R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 11, 2005REGVLAW OFFICE REGISTRATION REVIEW COMPLETED—
Feb 11, 2005ALIEASSIGNED TO LIE—
Jan 24, 2005CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jan 7, 2005SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Dec 21, 2004IUAFUSE AMENDMENT FILED—
Dec 21, 2004EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jun 29, 2004NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 6, 2004PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 17, 2004NPUBNOTICE OF PUBLICATION—
Jan 30, 2004CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 18, 2004DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance